Organigram Global (OGI) Non-Current Deferred Tax Liability (2018 - 2023)
Organigram Global (OGI) posted quarterly Non-Current Deferred Tax Liability of $10.3 million for Q3 2023, up 265.57% on a QoQ basis from $2.8 million in Q3 2022.
Organigram Global (OGI) Non-Current Deferred Tax Liability (2018 - 2023) Analysis & Trends
Organigram Global (OGI) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $10.3 million the latest figure, recorded in Q3 2023.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $10.3 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $10.3 million (changed N/A YoY) and the FY2023 annual result came in at $10.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability rose to $10.3 million in Q3 2023 per OGI's latest filing, from $2.8 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for OGI reached as high as $16.8 million in Q2 2019 and fell as low as $2.8 million in Q3 2022.
- A 4-year average of $11.2 million and a median of $10.3 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- The largest YoY upside for Non-Current Deferred Tax Liability was 14.79% in 2019 against a maximum downside of 14.79% in 2019.
- Year by year, Non-Current Deferred Tax Liability stood at $16.0 million in 2019, then sank by 37.73% to $10.0 million in 2020, then tumbled by 71.84% to $2.8 million in 2022, then soared by 265.57% to $10.3 million in 2023.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $10.3 million, $2.8 million, and $10.0 million for Q3 2023, Q3 2022, and Q1 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10.27 Mn |
| Sep 30, 2023 | 10.27 Mn |
| Aug 31, 2022 | 2.81 Mn |
| Aug 31, 2022 | 2.81 Mn |
| Feb 29, 2020 | 9.98 Mn |
| Feb 29, 2020 | 9.98 Mn |
| Aug 31, 2019 | 16.02 Mn |
| Aug 31, 2019 | 16.02 Mn |
| May 31, 2019 | 16.76 Mn |
| May 31, 2019 | 16.76 Mn |
| Aug 31, 2018 | 13.96 Mn |
| Aug 31, 2018 | 13.96 Mn |